Primary Site >> Colorectal Cancer
Gene >> CX3CR1
| 1. | |||||||||||
| Journal: | Int J Colorectal Dis. 2007 Oct;22(10):1195-200. Epub 2007 Jul 5. | ||||||||||
| Title: | Polymorphisms of Fractalkine receptor CX3CR1 and plasma levels of its ligand CX3CL1 in colorectal cancer patients. | ||||||||||
| Author: | Dimberg, Jan|Dienus, Olaf|Lofgren, Sture|Hugander, Anders|Wagsater, Dick | ||||||||||
| PMID: | 17611763 | ||||||||||
| 2. | |||||||||||
| Journal: | Cancer Gene Ther. 2013 May;20(5):308-16. | ||||||||||
| Title: | The use of hypoxic cultured mesenchymal stem cell for oncolytic virus therapy. | ||||||||||
| Author: | Huang, Y-F|Chen, M-J|Wu, M-H|Hung, S-C | ||||||||||
| PMID: | 23618949 | ||||||||||
| 3. | |||||||||||
| Journal: | Mol Cancer. 2013 Nov 18;12(1):141. | ||||||||||
| Title: | Chemokine receptor CX3CR1 contributes to macrophage survival in tumor metastasis. | ||||||||||
| Author: | Zheng, Jiao|Yang, Min|Shao, Jianghua|Miao, Yanju|Han, Jiahuai|Du, Jie | ||||||||||
| PMID: | 24245985 | ||||||||||
| 4. | |||||||||||
| Journal: | J Immunol. 2016 Jan 15;196(2):902-14. | ||||||||||
| Title: | The Fractalkine-Receptor Axis Improves Human Colorectal Cancer Prognosis by Limiting Tumor Metastatic Dissemination. | ||||||||||
| Author: | Erreni, Marco|Siddiqui, Imran|Marelli, Giulia|Grizzi, Fabio|Bianchi, Paolo|Morone, Diego|Marchesi, Federica|Celesti, Giuseppe|Pesce, Samantha|Doni, Andrea|Rumio, Cristiano|Roncalli, Massimo G|Laghi, Luigi|Mantovani, Alberto|Allavena, Paola | ||||||||||
| PMID: | 26673138 | ||||||||||
| 5. | |||||||||||
| Journal: | J Immunother Cancer. 2016 Apr 19;4:21. | ||||||||||
| Title: | Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient. | ||||||||||
| Author: | Siddiqui, Imran|Erreni, Marco|van Brakel, Mandy|Debets, Reno|Allavena, Paola | ||||||||||
| PMID: | 27096098 | ||||||||||
| 6. | |||||||||||
| Journal: | J Clin Invest. 2017 Aug 1;127(8):3039-3051. | ||||||||||
| Title: | Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy. | ||||||||||
| Author: | Jung, Keehoon|Heishi, Takahiro|Khan, Omar F|Kowalski, Piotr S|Incio, Joao|Rahbari, Nuh N|Chung, Euiheon|Clark, Jeffrey W|Willett, Christopher G|Luster, Andrew D|Yun, Seok Hyun|Langer, Robert|Anderson, Daniel G|Padera, Timothy P|Jain, Rakesh K|Fukumura, Da | ||||||||||
| PMID: | 28691930 | ||||||||||
| 7. | |||||||||||
| Journal: | Proc Natl Acad Sci U S A. 2017 Sep 26;114(39):10455-10460. | ||||||||||
| Title: | Targeting CXCR4-dependent immunosuppressive Ly6C(low) monocytes improves antiangiogenic therapy in colorectal cancer. | ||||||||||
| Author: | Jung, Keehoon|Heishi, Takahiro|Incio, Joao|Huang, Yuhui|Beech, Elizabeth Y|Pinter, Matthias|Ho, William W|Kawaguchi, Kosuke|Rahbari, Nuh N|Chung, Euiheon|Kim, Jun Ki|Clark, Jeffrey W|Willett, Christopher G|Yun, Seok Hyun|Luster, Andrew D|Padera, Timothy P | ||||||||||
| PMID: | 28900008 | ||||||||||